Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Clinical Drug Investigation
|
July 1, 2010
Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuation
Annalisa Arcese, Nicola Aste, Alberta Bettacchi, et al.
Clinical, Cosmetic and Investigational Dermatology
|
April 10, 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
Marina Talamonti, Filomena Russo, Giovanna Malara, et al.
Dermatology and Therapy
|
January 23, 2025
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, et al.
Italian Journal of Dermatology and Venereology
|
April 23, 2024
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens
Luca Stingeni, Leonardo Bianchi, Elena S Caroppo, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
American Journal of Clinical Dermatology
|
September 19, 2023
AtopyReg<sup>®</sup>, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
Luca Stingeni, Andrea Chiricozzi, Piergiacomo Calzavara-Pinton, et al.
Archives of Dermatological Research
|
May 23, 2025
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis)
Luca Potestio, Cataldo Patruno, Alessandra Narcisi, et al.
Clinical and Experimental Dermatology
|
February 3, 2025
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter Experience
Francesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Journal of Clinical Medicine
|
March 27, 2025
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes
Francesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Dermatology and Therapy
|
July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian Consensus
Ketty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Clinical Drug Investigation
|
July 1, 2010
Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuation
Annalisa Arcese, Nicola Aste, Alberta Bettacchi, et al.
Clinical, Cosmetic and Investigational Dermatology
|
April 10, 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
Marina Talamonti, Filomena Russo, Giovanna Malara, et al.
Dermatology and Therapy
|
January 23, 2025
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, et al.
Italian Journal of Dermatology and Venereology
|
April 23, 2024
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens
Luca Stingeni, Leonardo Bianchi, Elena S Caroppo, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
American Journal of Clinical Dermatology
|
September 19, 2023
AtopyReg<sup>®</sup>, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
Luca Stingeni, Andrea Chiricozzi, Piergiacomo Calzavara-Pinton, et al.
Archives of Dermatological Research
|
May 23, 2025
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis)
Luca Potestio, Cataldo Patruno, Alessandra Narcisi, et al.
Clinical and Experimental Dermatology
|
February 3, 2025
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter Experience
Francesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Journal of Clinical Medicine
|
March 27, 2025
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes
Francesca Barei, Paolo Calzari, Elena Pezzolo, et al.
Dermatology and Therapy
|
July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian Consensus
Ketty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
Page
of 7